Houston, TX – According to filings with the U.S. Securities and Exchange Commission, Luna Genetics is raising $4,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Arthur Beaudet played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Luna Genetics

Luna Genetics will be a company run by women for women. At every level, from the CEO to the lab technician to the genetic counselor, Luna pledges to have the company staffed by at least 75% women. Our first hires have been women. Luna Genetics was founded in 2018 for the purpose of developing new technologies to capture fetal cells in maternal blood early in pregnancy and use advanced DNA analytic techniques to search for serious genetic abnormalities. By capturing fetal cells from maternal blood, Luna will use Single Cell Prenatal Diagnosis (SCPD) to create a new standard of care that will permit safe and detailed analysis of the fetal genome early in pregnancy.

To learn more about Luna Genetics, visit http://lunagenetics.com/

Contact:
Arthur Beaudet, Chief Executive Officer
346-355-0111
https://www.linkedin.com/in/arthur-beaudet-b8aba11a8/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved